Northern Trust Corp F Star Therapeutics, Inc. Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$4.71 - $7.38 $268 - $420	-57 Reduced 0.16%	35,102 $176,000
Q3 2021 Nov 15, 2021	BUY	$5.2 - $8.42 $3,676 - $5,952	707 Added 2.05%	35,159 $257,000
Q2 2021 Aug 13, 2021	BUY	$6.57 - $10.71 $105,172 - $171,445	16,008 Added 86.79%	34,452 $296,000
Q1 2021 May 12, 2021	BUY	$7.09 - $13.84 $56,677 - $110,636	7,994 Added 76.5%	18,444 $200,000
Q4 2020 Feb 11, 2021	BUY	$1.03 - $10.39 $10,763 - $108,575	10,450 New	10,450 $103,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.